HPI (Hypotension Prediction Index) Care Trial

See also
Status	Clinical Trial	Phase
Terminated	`NCT05293106` - Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial	Phase 4
Completed	`NCT05184725` - CARINAE for Stress Relief in Perioperative Care	N/A
Completed	`NCT03861286` - Haemostatic Markers in Cardiopulmonary Bypass

See also

Status

Clinical Trial

Phase

Terminated

NCT05293106 - Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial

Phase 4

Completed

NCT05184725 - CARINAE for Stress Relief in Perioperative Care

N/A

Completed

NCT03861286 - Haemostatic Markers in Cardiopulmonary Bypass

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05083403
Study type	Interventional
Source	Edwards Lifesciences
Contact	Cristina Johnson
Phone	888.713.1564
Email	Cristine_Johnson@edwards.com
Status	Recruiting
Phase	N/A
Start date	March 28, 2022
Completion date	June 30, 2024

HPI (Hypotension Prediction Index) Care Trial

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms